This inventor holds 6 USPTO granted patents, plus 2 CIPO patents. Top assignees: Ajinomoto Co., Ltd., Japanese Foundation for Cancer Research. Active years: 1988-1998.
Location History:
- Kanagawa, JP (1988)
- Yokohama, JP (1988 - 1998)
Company Filing History:
6 out of 1,953 
2 out of 57 Years Active: 1988-1998
Title: Nobukazu Kashima: Innovator in Interleukin-2 Research
Introduction
Nobukazu Kashima is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant DNA technologies. With a total of six patents to his name, Kashima's work has had a profound impact on medical research and therapeutic applications.
Latest Patents
Kashima's latest patents include groundbreaking innovations related to interleukin-2. One of his notable patents involves gene encoding for interleukin-2 polypeptide. This patent describes a recombinant DNA that carries a gene coded for a polypeptide possessing interleukin-2. The recombinant DNA is isolated and connected with a vector DNA capable of replicating in prokaryotic or eukaryotic cells. This process allows for the transformation of cells to produce interleukin-2, which is crucial for various therapeutic applications.
Career Highlights
Throughout his career, Nobukazu Kashima has worked with esteemed organizations such as Ajinomoto Co., Ltd. and the Japanese Foundation for Cancer Research. His work in these institutions has allowed him to advance his research and contribute to significant scientific discoveries. His expertise in recombinant DNA technology has positioned him as a leader in the field.
Collaborations
Kashima has collaborated with notable scientists, including Tadatsugu Taniguchi and Masami Muramatsu. These collaborations have further enriched his research and have led to advancements in the understanding of interleukin-2 and its applications in medicine.
Conclusion
Nobukazu Kashima's contributions to biotechnology, particularly in the area of interleukin-2 research, have established him as a key figure in the field. His innovative patents and collaborations with other scientists highlight his commitment to advancing medical science. His work continues to inspire future research and development in biotechnology.